BI
AZN icon

Bramshill Investments’s AstraZeneca AZN Stock Holding History

Bramshill Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-139
Closed -$11K – 115
2018
Q4 		$11K Sell
139
-39
-22% -$3.04K ﹤0.01% 132
2018
Q3 		$14K Buy
+178
New +$13.5K ﹤0.01% 148

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bramshill Investments's AZN Position: Q1 2019 in Review

Bramshill Investments sold out of AstraZeneca (AZN) in Q1 2019, closing a stake of 139 shares — an estimated $11K sold.

Bramshill Investments first reported a position in AZN in Q3 2018 and held it in 2 quarters. The position peaked at $14K in Q3 2018. 559 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

  • Bramshill Investments reported no remaining AstraZeneca position as of Q1 2019 after selling out during the quarter.
  • Bramshill Investments sold 139 AstraZeneca shares in Q1 2019, an estimated $11K.
  • Bramshill Investments first reported a position in AstraZeneca in Q3 2018 and held it in 2 quarters.
  • Bramshill Investments's AstraZeneca position peaked at $14K in Q3 2018.
  • 559 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on Bramshill Investments's 13F filing for Q1 2019, filed 15 May 2019.